LONG TERM EFFECTS OF LITHIUM ON GLOMERULAR FILTRATION RATE IN INDIAN SUBJECTS - A CROSS SECTIONAL STUDY by Singh, Baljinder et al.
Indian Journal of Psychiatry, 2000, 42 (4), 410-414 
LONG TERM EFFECTS OF LITHIUM ON GLOMERULAR FILTRATION 
RATE IN INDIAN SUBJECTS - A CROSS SECTIONAL STUDY 
BALJINDER SINGH, BHAGWANT R. MITTAL, KAMAL SUD, ANISH BHATTACHARYA, 
PRATAP SHARAN, SURINDER K. JINDAL & SHRIDHAR D. DEODHAR 
ABSTRACT 
Glomerular filtration rate (GFR) was evaluated in thirty patients on lithium and in thirty healthy 
prospective kidney donors by single compartment, multiple sample plasma clearance method using 
""Technetium diethylene triamine pentaacetic acid ("
mTC-DTPA). Normality test revealed that dose 
and treatment duration were skewed and the coefficient of skewness were 0.067 (p<0.0001) and 
1.41 (p<0.0001) respectively. Age was marginally skewed (p =0.04) for the control group. At 5% 
significance level, dose and creatinine were negatively correlated (r =-0.030). whereas age and 
duration were positively correlated (r =+ 0.53) (single tailed only). Duration and GFR seems to be 
negatively correlated (r = -0.23), however this correlation did not reach statistically significance 
level. In the present cross sectional study no significant difference in mean GFR was observed in 
lithium treated affective disorder patients when compared with the age matched normal subjects. 
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The potential therapeutic uses of lithium 
(Li) salts were suggested in the nineteenth 
century, however, the immense benefit of Li in 
psychiatric practice has been realized since last 
5 decades (Reifman & Wyatt,1980). Lithium 
treatment may lead to changes in various organ 
functions and as a part of evaluating the side 
effects of Li, we have reported that it causes 
sub-clinical hypothyroidism in a significant 
number of Li treated patients (Deodhar et al., 
1999) and also causes alterations in the blood 
levels of various essential elements including 
sodium and potassium in humans (Singh et 
al.,1998) and animals (Singh et al.,1994). 
Currently, it is estimated that at any one 
time about 1:1000 of the populations of most 
western societies are taking Li prophylaxis for 
severe bipolar and unipolar affective disorders 
(Davison et al.,1998). The margin between 
'therapy' and 'toxicity' is so narrow that the most 
serious complications of lithium are acute lithium 
intoxication (Hansen & Amdisen,1978). As the 
kidneys almost exclusively excrete lithium, the 
development of acute Li-intoxication is usually 
due to decreased renal elimination of this ion. 
Given the wide spread use of lithium, it was 
alarming, but perhaps not so surprising, when 
the 1
s
t report of possible lithium induced chronic 
histological lesions of the kidneys appeared 
(Hestbech etal.,1997). 
Polyurea and polydypsia in-patients on 
chronic lithium treatment results from impaired 
urinary concentrating ability. The nephrogenic 
diabetes insipidus in these patients is because 
of insensitivity of the collecting ducts to 
exogenous and endogenous vasopressin, at the 
level of cellular vasopressin - sensitive adenylate 
cyclase activity. As the primary mode of 
excretion of lithium by the kidneys is reassorption 
from proximal tubules, recent studies have 
suggested lithium-induced abnormalities in 
proximal functions (Davison et al.,1989). 
Walker et al. (1982) reported that 
parameterrs to evaluate glomerular filtration 
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function i.e. serum creatinine,
 s1Chromium 
ethylene diamine tetra-acetic acid (
51Cr-EDTA) 
clearance and serum fl2-microglobulin in lithium 
treated patients demonstrated a significant 
impairment when compared with affective 
disorder (AD) patients not receiving the drug. 
Tyrer et al. (1983) also reported deterioration of 
glomerular filtration rate (GFR) with long-term 
lithium therapy. Further, Jensen and Rickers 
(1984) reported that after lithium therapy, a 
significant proportion of patients (10/13) had 
lower GFR when measured 2 years after lithium 
treatment. 
However, there had been a considerable 
lack of information on the chronic effect of lithium 
treatment on renal functions in Indian population. 
In view of this, the present cross sectional study 
was carried out with an ethnic prespective and 
the long term effect of lithium treatment on GFR 
was evaluated in AD patients. 
MATERIAL AND METHOD 
Study subjects and treatment: Thirty AD patients 
receiving lithium as lithium carbonate were 
enrolled for the present study. Thirty age 
matched healthy subjects who were prospective 
kidney donors and who had never received 
lithium or any other drug on a chronic basis that 
could affect renal functions were included as a 
control group. An informed written consent was 
obtained from all the subjects participating in the 
study. All the patients met DSM-III-R criteria for 
AD (APA.1987). These patients had previously 
received or were receiving medications other 
than lithium (viz. antipsychotics, antidepressants, 
anticholinergics and sedative hypnotic;. The 
patients' demographic details and the treatment 
schedule are presented in table-1. 
GFR evaluation : GFR was estimated using the 
plasma clearance method. An intravenous 
injection of approximately 20 MBq of 
""Technetium diethylene triamine pentaacetic 
acid (
99mTc-DTPA) was given to each study 
subject and a known quantity of radiotracer was 
kept as standard. Subsequently, two milliliters 
of venous blood was withdrawn from each patient 
at 60, 90, 120, 150 and 180 minutes by using 
disposable and heparinized needles and 
syringes. Heparinized blood samples were 
allowed to stand for 3-4h and plasma was 
separated. Radioactivity in the plasma samples, 
standard sample and wash solutions (0.5 ml 
each) was countered by using a well type gamma 
counter (Nuclear Enterprises, Edinburg, U.K.) 
The left over activity in the needles and syringes 
were also accounted for the -purpose of 
calculating the total activity in the wash solution. 
Absolute GFR was estimated by single 
compartment, multiple plasma clearance 
method and expressed in ml/min which was then 
normalized for weight and height of the patient 
and expressed as ml/min/1.73 m
2 (Russel et 
al.,1985). 
Estimation of serum Li levels : Serum Li levels 
were estimated by the flame photometry (Brown 
&Legg,1970). 
Statistics : Normality test, correlation analysis 
and student's 't' test were performed and the 
results were considered statistically significant 
when p value was < 0.05. For the test group, the 
values for various parameters were skewed 
whereas they were normal (non-skewed) for the 
control group. 
RESULTS 
Normality test revealed that dose and 
treatment duration were skewed and the 
coefficient of skewness were 0.067 (p<0 0001) 
and 1.41 (p<0.0001) respectively. Age was 
marginally skewed (p=0.04) for the control group. 
At 5% significance level, dose and creatinine 
were negatively correlated (r = -0.030), whereas 
age and duration were positively correlated (r = 
+0.53) (single tailed only) Duration and GFR 
seems to be negatively correlated (r = -0.23), 
however did not reach the significant level. 
The mean serum Li levels in the lithium 
treated AD patients were 0.72+0 19 mEq/L 
(range 0.42-1.19 mEq/L) and were in the 
therapeutic range. 
The mean GFR in AD patients undergoing 
lithium treatment and in the control group has 
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TABLE 1 
PATIENT'S DEMOGERAPHIC DETAILS, TREATMENT SCHEDULE AND ABSOLUTE GLOMERULAR 
FILTRATION RATE (GFR) IN TEST AND CONTROL GROUPS 
Group 
Lithium treated 
Control 
Number of 
subjects 
(M : F) 
30(20: 10) 
30(16; 14) 
Age 
(years) 
Mean=40.2±10.8 
Median=38 
(range=20-62) 
Mean=40.2±10.5 
Median=39 
(range=22-61) 
Lithium 
treatment 
(Li-dose in 
mg/day) 
Mean=895±150 
Median=900 mg 
Nil 
Treatment 
duration 
(months) 
Mean=86.6±66.6 
Median=60 
Nil 
Absolute GFR 
(mL/min) 
Mean=94.6±27.8 
Median=90 
(range=50-156) 
Mean=98.8±19.3 
Median=99 
(range=77-146) 
The difference in GFR amongst the test and the control 
been calculated to be 98.8±19.3 ml/min/1.73 m
2 
and 94.6±27.8 ml/min/1.73 m
2 respectively and 
the difference in GFR between the test and the 
control groups is statistically non-significant 
(Table 1). 
TABLE 2 
CORRELATION ANALYSIS AMONGST DIFFERENT 
VARIABLES IN THE TEST GROUP 
Age 
Dose 
Duration 
GFR 
Creatinin 
Age 
1.00 
-0.069 
0.53 
-0 19 
0.02 
Dose 
1.0 
-0.03 
0.11 
-0.29 
Duration 
1.0 
-023 
0.07 
GFR 
1.0 
0.10 
Creatinine 
1.0 
Critical values (1-tail, 0.05) = + or-0 3064 
DISCUSSION 
The first indication about progressive 
impairment of glomerular filtration rate in patients 
taking lithium on chronic basis came from 
Hestbech et al. (1977). This observation 
stimulated a number of cross sectional studies 
inpatients taking lithium and most failed to show 
evidence of impaired renal function (Miller et 
al.,1979; Perez etal,1975). In the present study, 
we had also observed similar findings of non-
impaired GFR in lithium treated AD patients. In 
a recent report (Kallner et af. ,1995) in a cohort 
of 207 patients receiving lithium, all the renal 
functions were observed to be within the 
reference range. Hetmar and Rafaelsen (1987) 
compared renal functions in 44 patients receiving 
lithium for an average of 8 years with that of AD 
groups is statistically non-significant 
patients not receiving lithium. They indicated that 
lithium clearance can be used as a measure of 
GFR and the results were not comparable with 
that of the AD awaiting initiation of lithium 
therapy. Further, they observed a significant 
correlation with age, sex and GFR. We have not 
observed any correlation between age and GFR 
in lithium treated patients, however treatment 
duration and GFR in the present study seems to 
be negatively correlated (r = -0.23), but was 
significant. Furthermore, we have not seen any 
correlation between GFR and Li-dosing and the 
similar observations had been made by Hetmar 
and Rafaelson (1987). Acute reduction in GFR 
associated with acute toxicity can result in acute 
renal failure secondary to acute tubular necrosis. 
Some patients may require temporary dialysis 
support and this impairment of GFR is entirely 
reversible. Unlike, the relationship between 
impaired urinary concentrating ability and 
duration of lithium therapy, a progressive 
deterioration in GFR with duration of lithium 
therapy and/or total lithium dose has not 
generally been observed in patients on stable 
maintenance therapy without episodes of acute 
lithium intoxication. A review of 1172 patients 
treated with lithium from 14 reported series 
(Boton et al.,1987) suggests that approximately 
15% of those on maintenance therapy have GFR 
less than age-correlated 95% confidence limits. 
Occasional cross sectional studies, indicate that 
patients with impaired GFR tend to be in a group 
that has been taking lithium for many years. 
Studies in patients with shorter duration of lithium 
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treatment may not be able to detect a subtle 
progressive decline in GFR. As opposed to cross 
sectional studies, long term prospective studies 
in patients on lithium establish age related 
decline in GFR rather than a clear relationship 
between lithium exposure and GFR. 
Although, concurrent use of other 
psychotropic medication can theoretically affect 
GFR and has not been excluded in our study. 
Such a relationship has not been confirmed in 
the literature. Moreover, because of the small 
number of patients in this study and patients 
being prescribed a number of other psychotropic 
medication for varying periods of time, it will be 
extremely difficult to assess their effect, if any, 
on the GFR. 
It is thus inferred that the chronic use of 
lithium without any indication of lithium toxicity 
(serum lithium levels within physiological range) 
in affective disorder has no significant effect on 
GFR. Further in cross-sectional studies, 
evaluating effects of Li-treatment on renal 
functions, age matching amongst the Li-patients 
and control subjects should be necessarily 
considered. 
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